Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,605 | -54,662 | -34,491 | -12,928 | -71,109 |
| Depreciation Amortization | 213 | 144 | 95 | 37 | 167 |
| Accounts receivable | -769 | -515 | -603 | -361 | N/A |
| Accounts payable and accrued liabilities | 788 | 3,095 | -550 | 2,047 | 6 |
| Other Working Capital | -11,828 | -8,092 | -9,319 | -7,532 | 11,176 |
| Other Operating Activity | 10,574 | 6,654 | 7,536 | 1,374 | 8,238 |
| Operating Cash Flow | $-81,627 | $-53,376 | $-37,332 | $-17,363 | $-51,522 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 60,250 | -80,181 | -93,044 | -77,562 | N/A |
| PPE Investments | -155,466 | -607 | -585 | -426 | -366 |
| Investing Cash Flow | $-95,216 | $-80,788 | $-93,629 | $-77,988 | $-366 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -6,000 | -4,500 | -3,000 | -1,500 | -6,000 |
| Common Stock Issued | 714 | N/A | N/A | N/A | 212,395 |
| Other Financing Activity | 16,755 | -44 | 0 | 0 | 174,804 |
| Financing Cash Flow | $11,469 | $-4,544 | $-3,000 | $-1,500 | $381,199 |
| Exchange Rate Effect | -87 | -68 | -58 | -12 | 81 |
| Beginning Cash Position | 354,349 | 354,349 | 354,349 | 354,349 | 24,957 |
| End Cash Position | 188,888 | 215,573 | 220,330 | 257,486 | 354,349 |
| Net Cash Flow | $-165,461 | $-138,776 | $-134,019 | $-96,863 | $329,392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,627 | -53,376 | -37,332 | -17,363 | -51,522 |
| Capital Expenditure | -155,466 | -607 | -585 | -426 | -366 |
| Free Cash Flow | -237,093 | -53,983 | -37,917 | -17,789 | -51,888 |